Pharmacovigilance
192102, Russia, Saint Petersburg,
Salova St., 72, building 2, lit. A.
Pharmacovigilance Group
of the Medical Department.
STPF «POLYSAN» LTD ensures the safety of its products at every stage of drug development and after their introduction into clinical practice. If you become aware of any adverse reactions when using STPF «POLYSAN» LTD medicinal products or any other events that may be related to the safety of the products, you can report them in any way convenient for you:
You may use the Adverse Event Reporting Form to submit your information
Download FormAny information regarding the safety, efficacy, and quality of STPF «POLYSAN» LTD products is crucial for assessing potential health risks to patients when taking the company’s products and for implementing the necessary risk minimization measures. STPF «POLYSAN» LTD thanks you in advance for your cooperation!